REdI Conference
The Regulatory Education for Industry (REdI) Program is a free FDA-led conference that brings together the regulatory educators from the FDA's medical product centers: Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Biologics Evaluation and Research (CBER). There is no cost to register or attend the conference.
Goal:
To educate the regulatory community with current information about FDA’s regulation of drugs, devices, and biologics.
Audience:
Small manufacturers, researchers, and innovators seeking to learn about how the FDA regulates drugs, devices, and biologics medical products.
Program Series and Format:
- REdI 2026 will be held on May 19-20, 2026. The conference will take place in person, with an option to attend virtually.
- For each FDA medical product center, REdI features a plenary session that combines the themes of drugs (CDER), devices (CDRH), and biologics (CBER) regulatory policy.
- Topics span the total product life cycle.
- The Devices Track, led by CDRH, will feature premarket topics on Day 1 (May 19) and postmarket topics on Day 2 (May 20).